Showing items 1 - 4 of 4

Your selections:

Real-world treatment patterns and outcomes for patients with CLL using the Australian pharmaceutical benefits scheme (PBS) dataset

- Tam, Constantine, Zhao, Fei-Li, Azam, Safee, Li, Shu Chuen, Tang, Boxiong

Ibrutinib-related atrial fibrillation: a single center Australian experience

- Ezad, Saad, Khan, Arshad A., Cheema, Hooria, Ashraf, Asma, Ngo, Doan T. M., Sverdlov, Aaron L., Collins, Nicholas J.

Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT⁺ cancers

- Roberts, Kathryn G., Smith, Amanda M., Sim, Alistair T. R., Ashman, Leonie K., Verrills, Nicole M., McDougall, Fiona, Carpenter, Helen, Horan, Martin, Neviani, Paolo, Powell, Jason A., Thomas, Daniel, Guthridge, Mark A., Perrotti, Danilo

Monoclonal gammopathy and glomerulopathy associated with chronic lymphocytic leukemia

- Vilayur, Eswari, Trevillian, Paul, Walsh, Mark

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit